
Arthur S. Leonard
Examiner (ID: 12301, Phone: (571)270-3073 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1631, 1633 |
| Total Applications | 655 |
| Issued Applications | 267 |
| Pending Applications | 112 |
| Abandoned Applications | 289 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11350224
[patent_doc_number] => 20160368964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'TRIFUNCTIONAL T CELL-ANTIGEN COUPLER AND METHODS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/117173
[patent_app_country] => US
[patent_app_date] => 2015-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12926
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15117173
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/117173 | Trifunctional T cell-antigen coupler and methods and uses thereof | Feb 5, 2015 | Issued |
Array
(
[id] => 11901069
[patent_doc_number] => 09770489
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-26
[patent_title] => 'Methods and products for nucleic acid production and delivery'
[patent_app_type] => utility
[patent_app_number] => 14/761461
[patent_app_country] => US
[patent_app_date] => 2015-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 37184
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14761461
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/761461 | Methods and products for nucleic acid production and delivery | Jan 29, 2015 | Issued |
Array
(
[id] => 10331143
[patent_doc_number] => 20150216148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'ORANGE TRANSGENIC FLUORESCENT ORNAMENTAL FISH'
[patent_app_type] => utility
[patent_app_number] => 14/609665
[patent_app_country] => US
[patent_app_date] => 2015-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2850
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14609665
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/609665 | Orange transgenic fluorescent ornamental fish | Jan 29, 2015 | Issued |
Array
(
[id] => 11772051
[patent_doc_number] => 09380768
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Red transgenic fluorescent ornamental fish'
[patent_app_type] => utility
[patent_app_number] => 14/609717
[patent_app_country] => US
[patent_app_date] => 2015-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2850
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14609717
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/609717 | Red transgenic fluorescent ornamental fish | Jan 29, 2015 | Issued |
Array
(
[id] => 10814025
[patent_doc_number] => 20160160186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'THERAPEUTIC PHAGES AND METHODS FOR DELIVERY OF NUCLEIC ACIDS FOR THERAPEUTIC USES'
[patent_app_type] => utility
[patent_app_number] => 14/605320
[patent_app_country] => US
[patent_app_date] => 2015-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9157
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14605320
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/605320 | Therapeutic phages and methods for delivery of nucleic acids for therapeutic uses | Jan 25, 2015 | Issued |
Array
(
[id] => 11130576
[patent_doc_number] => 20160327551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'SERS NANOPARTICLES AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/108555
[patent_app_country] => US
[patent_app_date] => 2015-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15370
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108555
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/108555 | SERS NANOPARTICLES AND METHODS FOR USING THE SAME | Jan 22, 2015 | Abandoned |
Array
(
[id] => 11270773
[patent_doc_number] => 20160333321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'ASSAY AND MEDICAMENT'
[patent_app_type] => utility
[patent_app_number] => 15/111615
[patent_app_country] => US
[patent_app_date] => 2015-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16557
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15111615
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/111615 | ASSAY AND MEDICAMENT | Jan 15, 2015 | Abandoned |
Array
(
[id] => 10234562
[patent_doc_number] => 20150119556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => 'Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same'
[patent_app_type] => utility
[patent_app_number] => 14/589249
[patent_app_country] => US
[patent_app_date] => 2015-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 71
[patent_figures_cnt] => 71
[patent_no_of_words] => 54996
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589249
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/589249 | Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same | Jan 4, 2015 | Abandoned |
Array
(
[id] => 10333543
[patent_doc_number] => 20150218547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'Cell Line, System and Method for Optical Control of Secondary Messengers'
[patent_app_type] => utility
[patent_app_number] => 14/589756
[patent_app_country] => US
[patent_app_date] => 2015-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7184
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589756
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/589756 | Cell line, system and method for optical control of secondary messengers | Jan 4, 2015 | Issued |
Array
(
[id] => 10813712
[patent_doc_number] => 20160159873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'RESEARCH BIO-NANOPARTICLE ELEMENTS AND PLATFORMS'
[patent_app_type] => utility
[patent_app_number] => 14/562051
[patent_app_country] => US
[patent_app_date] => 2014-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 33653
[patent_no_of_claims] => 213
[patent_no_of_ind_claims] => 163
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562051
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/562051 | RESEARCH BIO-NANOPARTICLE ELEMENTS AND PLATFORMS | Dec 4, 2014 | Abandoned |
Array
(
[id] => 10268329
[patent_doc_number] => 20150153326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'QUANTITATIVE ANALYSIS OF CONTACT-DEPENDENT CELL-TO-CELL TRANSFER AND DISEASE TRANSMISSION'
[patent_app_type] => utility
[patent_app_number] => 14/553281
[patent_app_country] => US
[patent_app_date] => 2014-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16460
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14553281
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/553281 | QUANTITATIVE ANALYSIS OF CONTACT-DEPENDENT CELL-TO-CELL TRANSFER AND DISEASE TRANSMISSION | Nov 24, 2014 | Abandoned |
Array
(
[id] => 11099593
[patent_doc_number] => 20160296562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'CELL'
[patent_app_type] => utility
[patent_app_number] => 15/037391
[patent_app_country] => US
[patent_app_date] => 2014-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 21639
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/037391 | CELL | Nov 20, 2014 | Abandoned |
Array
(
[id] => 11100890
[patent_doc_number] => 20160297860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'IDENTIFICATION OF A NOVEL B CELL CYTOKINE'
[patent_app_type] => utility
[patent_app_number] => 15/036207
[patent_app_country] => US
[patent_app_date] => 2014-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 18850
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036207
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/036207 | IDENTIFICATION OF A NOVEL B CELL CYTOKINE | Nov 19, 2014 | Abandoned |
Array
(
[id] => 10311582
[patent_doc_number] => 20150196584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'OXYGEN-CONTROLLABLE AND HYPOXIA-INDUCIBLE HYDROGELS'
[patent_app_type] => utility
[patent_app_number] => 14/536392
[patent_app_country] => US
[patent_app_date] => 2014-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 19611
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14536392
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/536392 | OXYGEN-CONTROLLABLE AND HYPOXIA-INDUCIBLE HYDROGELS | Nov 6, 2014 | Abandoned |
Array
(
[id] => 10219870
[patent_doc_number] => 20150104863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'VECTORS AND SEQUENCES FOR THE TREATMENT OF DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/531200
[patent_app_country] => US
[patent_app_date] => 2014-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10976
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14531200
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/531200 | Vectors and sequences for the treatment of diseases | Nov 2, 2014 | Issued |
Array
(
[id] => 11046301
[patent_doc_number] => 20160243260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'Treatment of neurological diseases using adeno-associated virus (AAV) comprising AAV-5 capsid proteins'
[patent_app_type] => utility
[patent_app_number] => 15/031782
[patent_app_country] => US
[patent_app_date] => 2014-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15750
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15031782
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/031782 | Treatment of neurological diseases using adeno-associated virus (AAV) comprising AAV-5 capsid proteins | Oct 23, 2014 | Abandoned |
Array
(
[id] => 11350557
[patent_doc_number] => 20160369298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'SYNTHETIC COMBINATORIAL AAV CAPSID LIBRARY FOR TARGETED GENE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/024431
[patent_app_country] => US
[patent_app_date] => 2014-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21436
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024431
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/024431 | SYNTHETIC COMBINATORIAL AAV CAPSID LIBRARY FOR TARGETED GENE THERAPY | Sep 25, 2014 | Abandoned |
Array
(
[id] => 10209529
[patent_doc_number] => 20150094518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'MODULAR POLYMER PLATFORM FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/498005
[patent_app_country] => US
[patent_app_date] => 2014-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 22245
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14498005
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/498005 | MODULAR POLYMER PLATFORM FOR THE TREATMENT OF CANCER | Sep 25, 2014 | Abandoned |
Array
(
[id] => 11323877
[patent_doc_number] => 20160354489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'GENE THERAPY COMPOSITIONS FOR USE IN THE PREVENTION AND/OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/024821
[patent_app_country] => US
[patent_app_date] => 2014-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16476
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024821
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/024821 | GENE THERAPY COMPOSITIONS FOR USE IN THE PREVENTION AND/OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE | Sep 24, 2014 | Abandoned |
Array
(
[id] => 16756818
[patent_doc_number] => 10975358
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Method for improving efficiency of inducing pluripotent stem cell
[patent_app_type] => utility
[patent_app_number] => 15/023484
[patent_app_country] => US
[patent_app_date] => 2014-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 25872
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023484
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/023484 | Method for improving efficiency of inducing pluripotent stem cell | Sep 23, 2014 | Issued |